IGM Financial Inc. (IGM) (TSX:IGM) today announced senior leadership changes that provide continuity and build on the company's momentum.

IGM Financial Inc. (IGM or the Company) (TSX:IGM) today announced earnings results for the fourth quarter and the year ended December 31, 2025.

Power Corp. of Canada chose former investment banker James O’Sullivan as its chief executive officer, taking over from ...

IGM Financial Inc. announced Q4 adjusted net earnings of $301.4 million on Thursday, a 20.6% year-over-year quarterly increase and a record high. Fourth quarter adjusted earnings per share came in at ...

Sanofi has continued the breakneck pace of dealmaking activity, paying $150 million upfront to make IGM Biosciences the third partner added in a hectic month for its business development team. The ...

IGM Biosciences, Inc. operates as a biotechnology company, which develops antibodies for the treatment of cancer. It offers the IgM platform to expand upon the inherent properties of IgM antibodies ...